Is ABBV or ABT cheaper?

On trailing earnings, ABT is cheaper: ABBV trades at a 111.67 P/E and ABT at 24.56.

Which has grown faster, ABBV or ABT?

Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus ABT at 3.87%.

Does ABBV or ABT pay a bigger dividend?

ABBV yields 2.96% and ABT yields 2.77% based on trailing dividends and the latest price.

Is ABBV or ABT more profitable?

ABT runs the higher net margin — ABBV at 5.79% versus ABT at 13.91%.

Which has been the better investment, ABBV or ABT?

Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus ABT at 10.72%. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Abbott Laboratories (ABT)

ABBV leads on 9 of 15 compared metrics, though ABT is the cheaper stock.

A side-by-side comparison of AbbVie Inc. and Abbott Laboratories across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ABBV vs ABT

growth of $100 · last 14y

ABBV +550.7%ABT +182.2%ABBV compounded faster

ABBV ABT

ABBV vs ABT: by the numbers

•ABBV is the larger company ($402.35B vs $153.59B market cap).
•ABT trades at the lower earnings multiple (24.56 vs 111.67 P/E).
•ABT converts more revenue to profit (13.91% vs 5.79% net margin).
•ABBV grew revenue faster over the past five years (4.59% vs 3.87% CAGR).
•ABBV pays the higher dividend yield (2.96% vs 2.77%).

Which is better, ABBV or ABT?

Metric tally: ABBV 9 · ABT 6

It depends on what you're optimizing for:

ValueABT(lower P/E)

GrowthABBV(faster 5Y revenue CAGR)

IncomeABBV(higher dividend yield)

QualityABBV(higher ROIC)

Valuation

Metric	ABBV	ABT
P/E ratio	111.67	24.56●
Forward P/E	—	14.56
P/S ratio	6.43	3.41●
P/B ratio	14.69	2.96●
PEG ratio	—	2.99
EV / EBITDA	27.63	17.30●
FCF yield	5.17%●	4.79%

Profitability

Metric	ABBV	ABT
Gross margin	70.68%●	56.38%
Operating margin	27.60%●	18.17%
Net margin	5.79%	13.91%●
ROE	13.23%●	12.06%
ROIC	12.97%●	8.43%

Dividends

Metric	ABBV	ABT
Dividend yield	2.96%●	2.77%
Payout ratio	284.39%	65.24%

Growth (annualized)

Metric	ABBV	ABT
Revenue CAGR (5Y)	4.59%●	3.87%
EPS CAGR (5Y)	-2.79%	8.22%●
FCF CAGR (5Y)	3.24%●	-0.61%
Total return CAGR (5Y)	18.95%●	-2.49%

Frequently asked

Which is better, ABBV or ABT?: It depends on your goal. value: ABT (lower P/E); growth: ABBV (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: ABBV (higher ROIC). Across all compared metrics, ABBV leads 9 to 6.
Is ABBV or ABT cheaper?: On trailing earnings, ABT is cheaper: ABBV trades at a 111.67 P/E and ABT at 24.56.
Which has grown faster, ABBV or ABT?: Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus ABT at 3.87%.
Does ABBV or ABT pay a bigger dividend?: ABBV yields 2.96% and ABT yields 2.77% based on trailing dividends and the latest price.
Is ABBV or ABT more profitable?: ABT runs the higher net margin — ABBV at 5.79% versus ABT at 13.91%.
Which has been the better investment, ABBV or ABT?: Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus ABT at 10.72%. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full ABT analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Abbott Laboratories P/E ratio AbbVie dividend yield Abbott Laboratories dividend yield AbbVie ROE Abbott Laboratories ROE AbbVie operating margin Abbott Laboratories operating margin AbbVie revenue growth Abbott Laboratories revenue growth AbbVie free cash flow Abbott Laboratories free cash flow

AbbVie & Abbott Laboratories appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.